Helsinn, Specialised Therapeutics Australia sales and marketing update

Helsinn Healthcare granted Specialised Therapeutics exclusive rights to commercialize Aloxi palonosetron in Australia and New Zealand. Further deal terms were not disclosed. Following the deal, Speci...